| Year |
Citation |
Score |
| 2019 |
Pearson T, Caporaso JG, Yellowhair M, Bokulich NA, Padi M, Roe DJ, Wertheim BC, Linhart M, Martinez JA, Bilagody C, Hornstra H, Alberts DS, Lance P, Thompson PA. Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development. Cancer Medicine. PMID 30652422 DOI: 10.1002/Cam4.1965 |
0.313 |
|
| 2019 |
Jameson GS, Borazanci EH, Rabinowitz J, Ansaldo K, LeGrand S, Propper D, Snyder C, Gordon M, Roe D, Hoff DDV. Abstract B27: A phase Ib/II trial of high-dose (HD) ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (MPC) Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B27 |
0.325 |
|
| 2019 |
Pathak KV, Lee S, McGilvrey M, Mansfield K, Cridebring D, Roe DJ, Whitsett TG, Park K, Pirrotte P. Abstract LB-297: Metabolic alterations in plasma associated with survival in small cell lung cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-297 |
0.326 |
|
| 2018 |
Kohler LN, Harris RB, Oren E, Roe DJ, Lance P, Jacobs ET. Adherence to Nutrition and Physical Activity Cancer Prevention Guidelines and Development of Colorectal Adenoma. Nutrients. 10. PMID 30115827 DOI: 10.3390/Nu10081098 |
0.334 |
|
| 2018 |
Chung VM, Borazanci EH, Jameson GS, Evans R, Downes M, Truitt ML, Patel H, Lowy AM, Roe D, Ansaldo K, Barrett MT, Korn RL, Caldwell L, Slethaug G, Hultsch R, et al. A SU2C catalyst randomized phase II trial of pembrolizumab with or without paricalcitol in patients with stage IV pancreatic cancer who have been placed in best possible response. Journal of Clinical Oncology. 36: TPS4154-TPS4154. DOI: 10.1200/Jco.2018.36.15_Suppl.Tps4154 |
0.317 |
|
| 2017 |
Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, Galons JP, Thompson PA. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Research and Treatment. PMID 28560655 DOI: 10.1007/S10549-017-4292-7 |
0.303 |
|
| 2016 |
Lance P, Alberts DS, Thompson PA, Fales L, Wang F, San Jose J, Jacobs ET, Goodman PJ, Darke AK, Yee M, Minasian L, Thompson IM, Roe DJ. Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 27777235 DOI: 10.1158/1940-6207.Capr-16-0104 |
0.308 |
|
| 2016 |
Martinez JA, Chalasani P, Thomson CA, Roe D, Altbach M, Galons JP, Stopeck A, Thompson PA, Villa-Guillen DE, Chow HH. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol. Bmc Cancer. 16: 500. PMID 27430256 DOI: 10.1186/S12885-016-2551-3 |
0.3 |
|
| 2016 |
Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27340121 DOI: 10.1158/1055-9965.Epi-16-0121 |
0.319 |
|
| 2015 |
Chalasani P, Marron M, Roe D, Clarke K, Iannone M, Livingston RB, Shan JS, Stopeck AT. A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer. Cancer Medicine. 4: 1051-9. PMID 25826750 DOI: 10.1002/Cam4.447 |
0.347 |
|
| 2015 |
Larkey LK, McClain D, Roe DJ, Hector RD, Lopez AM, Sillanpaa B, Gonzalez J. Randomized Controlled Trial of Storytelling Compared to a Personal Risk Tool Intervention on Colorectal Cancer Screening in Low-Income Patients. American Journal of Health Promotion : Ajhp. PMID 25615708 DOI: 10.4278/Ajhp.131111-Quan-572 |
0.311 |
|
| 2015 |
Thomson CA, Thompson PA, Wertheim BC, Roe D, Marron MT, Galons J, Kupinski MA, Altbach MI, Maskarinec G, Stopeck A. Abstract P6-01-18: 2-Hydroxyestrone is associated with breast density measured by mammography and fat:water ratio magnetic resonance imaging in women taking tamoxifen Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-01-18 |
0.312 |
|
| 2013 |
Bartley AN, Parikh N, Hsu CH, Roe DJ, Buckmeier JA, Corley L, Phipps RA, Gallick G, Lance P, Thompson PA, Hamilton SR. Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia. Cancer Prevention Research (Philadelphia, Pa.). 6: 1162-70. PMID 24008128 DOI: 10.1158/1940-6207.Capr-13-0113 |
0.321 |
|
| 2013 |
Baker AF, Roe DJ, Laughren C, Cohen JL, Wright HM, Clouser MC, Cui H, Alberts DS, Chambers SK. Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer. Investigational New Drugs. 31: 160-6. PMID 22580577 DOI: 10.1007/S10637-012-9827-5 |
0.692 |
|
| 2013 |
Sardo CL, Ashbeck EL, Hibler EA, Roe D, Harris RB, Cisneroz M, Lance P, Martinez ME, Thomson CA, Thompson PA, Jacobs ET. Abstract A48: Sedentary behavior is associated with colorectal adenoma recurrence in men Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-A48 |
0.321 |
|
| 2012 |
Thompson P, Roe DJ, Fales L, Buckmeier J, Wang F, Hamilton SR, Bhattacharyya A, Green S, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Martinez ME, et al. Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention. Cancer Prevention Research (Philadelphia, Pa.). 5: 1381-93. PMID 23060037 DOI: 10.1158/1940-6207.Capr-12-0204 |
0.345 |
|
| 2010 |
Clouser MC, Roe DJ, Foote JA, Harris RB, Alberts DS. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence. Nutrition and Cancer. 62: 1058-66. PMID 21058193 DOI: 10.1080/01635581.2010.492089 |
0.681 |
|
| 2010 |
Chambers SK, Clouser MC, Baker AF, Roe DJ, Cui H, Brewer MA, Hatch KD, Gordon MS, Janicek MF, Isaacs JD, Gordon AN, Nagle RB, Wright HM, Cohen JL, Alberts DS. Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5320-8. PMID 21041183 DOI: 10.1158/1078-0432.Ccr-10-0974 |
0.686 |
|
| 2009 |
Thompson PA, Wertheim BC, Roe DJ, Ashbeck EL, Jacobs ET, Lance P, MartÃnez ME, Alberts DS. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prevention Research (Philadelphia, Pa.). 2: 1023-30. PMID 19952360 DOI: 10.1158/1940-6207.Capr-09-0234 |
0.326 |
|
| 2009 |
Clouser MC, Roe DJ, Foote JA, Harris RB. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial. Pharmacoepidemiology and Drug Safety. 18: 276-83. PMID 19226541 DOI: 10.1002/Pds.1718 |
0.675 |
|
| 2006 |
Clouser MC, Harris RB, Roe DJ, Saboda K, Ranger-Moore J, Duckett L, Alberts DS. Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2292-7. PMID 17119060 DOI: 10.1158/1055-9965.Epi-06-0405 |
0.677 |
|
| 2006 |
Clouser MC, Harris RB, Roe DJ. Reliability of Self Reported Sun Exposure Factors American Journal of Epidemiology. 163. DOI: 10.1093/Aje/163.Suppl_11.S91-B |
0.637 |
|
| 2005 |
Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, et al. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. Journal of the National Cancer Institute. 97: 846-53. PMID 15928305 DOI: 10.1093/Jnci/Dji144 |
0.682 |
|
| 2004 |
Frank DH, Roe DJ, Chow HH, Guillen JM, Choquette K, Gracie D, Francis J, Fish A, Alberts DS. Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 299-303. PMID 14973093 DOI: 10.1158/1055-9965.Epi-03-0163 |
0.327 |
|
| 2002 |
Heddens D, Alberts DS, Hannigan EV, Williams SD, Garcia D, Roe DJ, Bell J, Alvarez RD. Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment. Gynecologic Oncology. 86: 239-43. PMID 12217742 DOI: 10.1006/Gyno.2002.6726 |
0.3 |
|
| 2001 |
Foote JA, Harris RB, Giuliano AR, Roe DJ, Moon TE, Cartmel B, Alberts DS. Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults International Journal of Cancer. 95: 7-11. PMID 11241303 DOI: 10.1002/1097-0215(20010120)95:1<7::Aid-Ijc1001>3.0.Co;2-X |
0.319 |
|
| 1999 |
Earnest DL, Sampliner RE, Roe DJ, Van Leeuwen B, Guillen J, Reid M, Martinez ME, Marshall JR, Alberts DS. Progress report: The Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps American Journal of Medicine. 106. PMID 10089115 DOI: 10.1016/S0002-9343(99)00003-0 |
0.303 |
|
| 1992 |
Taylor CW, Alberts DS, Peng YM, Mccloskey TM, Matzner M, Roe DJ, Plezia PM, Grindey GB, Hamilton M, Seitz D. Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer Journal of the National Cancer Institute. 84: 1798-1802. PMID 1433369 DOI: 10.1093/Jnci/84.23.1798 |
0.349 |
|
| 1991 |
Alberts DS, Mason-liddil N, Plezia PM, Roe DJ, Dorr RT, Struck RF, Phillips JG. Lack of ranitidine effects on cyclophosphamide bon marrow toxicity or metabolism: A placebo-controlled clinical trial Journal of the National Cancer Institute. 83: 1739-1743. PMID 1770553 DOI: 10.1093/Jnci/83.23.1739 |
0.313 |
|
| 1989 |
Taylor CW, Alberts DS, Ketcham MA, Satterlee WG, Holdsworth MT, Plezia PM, Peng YM, McCloskey TM, Roe DJ, Hamilton M, Salmon SE. Clinical pharmacology of a novel diarylsulfonylurea anticancer agent Journal of Clinical Oncology. 7: 1733-1740. PMID 2809686 DOI: 10.1200/Jco.1989.7.11.1733 |
0.328 |
|
| Show low-probability matches. |